Trump Administration Proposes $6.8 Billion Budget Cut for FDA
The Trump administration proposes a $6.8 billion budget for the FDA for 2026, a 5.5% reduction. The FDA, previously with a $7.2 billion budget, including user fees, faced staffing changes but maintained its review schedules. Discussions continue amid larger proposed cuts to health agencies.
The Trump administration has announced a $6.8 billion budget proposal for the U.S. Food and Drug Administration for fiscal year 2026, as stated by Commissioner Martin Makary. This represents a 5.5% reduction compared to its current $7.2 billion budget.
The proposal is part of a larger plan to cut U.S. health spending significantly, following earlier White House plans to reduce funding for agencies like the National Institutes of Health and the Centers for Disease Control and Prevention.
The FDA recently underwent major restructuring, resulting in layoffs and early retirements. However, officials assure that these changes have not affected approval timelines, with the agency on track to meet its treatment review targets.
ALSO READ
-
US Approves Potential Sale of F-35 Jets to Saudi Arabia, Shifting Middle Eastern Power Dynamics
-
FDA Pushes for Testosterone Therapies for Women: Breaking Down Barriers
-
US Eyes Controversial F-35 Deal to Bolster Saudi Defense
-
Trump's Battle to Shape the Kennedy Center Sparks Legal Drama
-
France's Ambitious Plan to Tame Deficit Amid Protests
Google News